Tumor mutation status of Hodgkin lymphoma survivors with secondary lung adenocarcinoma.
David Alan Bond
No relevant relationships to disclose
Gregory Alan Otterson
Consultant or Advisory Role - Boehringer Ingelheim; Genentech
Research Funding - Boehringer Ingelheim; Genentech; GlaxoSmithKline; Pfizer; Tragara Pharmaceuticals
Neil Dunavin
No relevant relationships to disclose